Chernew Michael E, Shah Mayur R, Wegh Arnold, Rosenberg Stephen N, Juster Iver A, Rosen Allison B, Sokol Michael C, Yu-Isenberg Kristina, Fendrick A Mark
Harvard Medical School, Boston, Massachusetts, USA.
Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. doi: 10.1377/hlthaff.27.1.103.
This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.
本文评估了一家大型雇主发起的基于价值的保险计划的效果，该计划旨在提高对推荐治疗方案的依从性。在疾病管理（DM）计划的背景下，该干预措施降低了五类慢性药物的自付费用。与采用相同DM计划的对照雇主相比，基于价值的干预措施中五类药物中有四类的药物依从性有所提高，非依从性降低了7%-14%。结果表明，降低高价值服务的自付费用有可能提高药物依从性，其效果超过现有DM计划的影响。
